• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素与秋水仙碱的双盲试验及环孢素治疗白塞病的长期开放性研究。

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.

作者信息

Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G

机构信息

Department of Ophthalmology, Faculty of Medicine, University of Tokyo, School of Medicine, Japan.

出版信息

Lancet. 1989 May 20;1(8647):1093-6. doi: 10.1016/s0140-6736(89)92381-7.

DOI:10.1016/s0140-6736(89)92381-7
PMID:2566048
Abstract

The efficacy and safety of oral cyclosporin 10 mg/kg per day in Behçet's disease were compared in a randomised double-masked study with those of colchicine, 1 mg orally per day, and were also investigated in a long-term open study. The double-masked study showed that cyclosporin was effective in treating not only the ocular manifestations of Behçet's disease but also oral aphthous ulcer, dermal lesions, and genital ulceration. Efficacy did not weaken during long-term treatment.

摘要

在一项随机双盲研究中,对比了每天口服10毫克/千克环孢素治疗白塞病的疗效和安全性与每天口服1毫克秋水仙碱的疗效和安全性,并且还在一项长期开放研究中进行了调查。双盲研究表明,环孢素不仅对白塞病的眼部表现有效,而且对口腔溃疡、皮肤病变和生殖器溃疡也有效。长期治疗期间疗效并未减弱。

相似文献

1
Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.环孢素与秋水仙碱的双盲试验及环孢素治疗白塞病的长期开放性研究。
Lancet. 1989 May 20;1(8647):1093-6. doi: 10.1016/s0140-6736(89)92381-7.
2
Cyclosporin A treatment of Behçet's disease: a long-term study.
Curr Eye Res. 1990;9 Suppl:17-23. doi: 10.3109/02713689008999414.
3
Short term cyclosporin A treatment of Behçet's disease.环孢素A短期治疗白塞病。
Br J Ophthalmol. 1987 May;71(5):387-90. doi: 10.1136/bjo.71.5.387.
4
[A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
Ryumachi. 2003 Feb;43(1):44-50.
5
A double-blind trial of colchicine in Behçet's syndrome.秋水仙碱治疗白塞病的双盲试验。
Arthritis Rheum. 2001 Nov;44(11):2686-92. doi: 10.1002/1529-0131(200111)44:11<2686::aid-art448>3.0.co;2-h.
6
Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.秋水仙碱与安慰剂治疗 Behçet 病的随机、双盲、对照交叉试验。
Mod Rheumatol. 2009;19(5):542-9. doi: 10.1007/s10165-009-0200-2. Epub 2009 Jul 14.
7
Behçet's disease.白塞病
Curr Opin Rheumatol. 1991 Feb;3(1):32-5.
8
Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.环磷酰胺和秋水仙碱治疗白塞病的长期疗效。
Ann Ophthalmol. 1991 Apr;23(4):148-51.
9
Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.英夫利昔单抗单药治疗与英夫利昔单抗和秋水仙碱联合治疗 Behçet 病患者的效果比较。
Ocul Immunol Inflamm. 2012 Jun;20(3):193-7. doi: 10.3109/09273948.2012.665124. Epub 2012 Apr 9.
10
Cyclosporin A in the treatment of severe Behçet's uveitis.
Br J Rheumatol. 1987 Aug;26(4):285-91. doi: 10.1093/rheumatology/26.4.285.

引用本文的文献

1
Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances.贝赫切特葡萄膜炎的解码:发病机制和治疗进展的深入综述。
J Neuroinflammation. 2024 May 22;21(1):133. doi: 10.1186/s12974-024-03123-6.
2
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies.优化贝赫切特葡萄膜炎的管理:个性化免疫抑制策略的综述。
Med Sci Monit. 2024 May 7;30:e943240. doi: 10.12659/MSM.943240.
3
Behçet's Disease, Pathogenesis, Clinical Features, and Treatment Approaches: A Comprehensive Review.白塞病:发病机制、临床特征及治疗方法的全面综述
Medicina (Kaunas). 2024 Mar 29;60(4):562. doi: 10.3390/medicina60040562.
4
[Non-infectious anterior uveitis : S1 guideline of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Version: 13.12.2023].[非感染性前葡萄膜炎:德国眼科学会(DOG)和德国眼科医生专业协会(BVA)S1指南。版本:2023年12月13日]
Ophthalmologie. 2025 Jan;122(Suppl 1):1-12. doi: 10.1007/s00347-024-02007-7. Epub 2024 Mar 4.
5
Disease and Treatment-Specific Complications of Behçet Syndrome.贝切特综合征的疾病和治疗相关并发症。
Curr Rheumatol Rep. 2024 Jan;26(1):1-11. doi: 10.1007/s11926-023-01124-7. Epub 2023 Nov 23.
6
Oral Lesions as the Primary Manifestations of Behçet's Disease: The Importance of Interdisciplinary Diagnostics-A Case Report.以口腔病变为主要表现的白塞病:多学科诊断的重要性——病例报告
Biomedicines. 2023 Jul 3;11(7):1882. doi: 10.3390/biomedicines11071882.
7
Behçet's Disease Uveitis.白塞病性葡萄膜炎
J Clin Med. 2023 May 24;12(11):3648. doi: 10.3390/jcm12113648.
8
Treatment Options in Pediatric Behçet's Disease.儿童贝赫切特病的治疗选择。
Paediatr Drugs. 2023 Mar;25(2):165-191. doi: 10.1007/s40272-022-00548-5. Epub 2023 Jan 10.
9
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.成人非感染性中间、后和全葡萄膜炎的非生物制剂、皮质类固醇保留疗法。
Cochrane Database Syst Rev. 2022 Oct 31;10(10):CD014831. doi: 10.1002/14651858.CD014831.pub2.
10
Behçet uveitis: Current practice and future perspectives.白塞氏葡萄膜炎:当前实践与未来展望。
Front Med (Lausanne). 2022 Sep 7;9:968345. doi: 10.3389/fmed.2022.968345. eCollection 2022.